(19Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt

(19Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt Struktur
220127-31-1
CAS-Nr.
220127-31-1
Englisch Name:
(19Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt
Synonyma:
(19Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt;(19E/Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt;2-Piperidinecarboxylic acid, 1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19Z,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-, sodium salt (1:1), (2S)-
CBNumber:
CB82544203
Summenformel:
C53H83NNaO14*
Molgewicht:
981.22
MOL-Datei:
220127-31-1.mol

(19Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt Eigenschaften

Sicherheit

(19Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Metabolite of the immunosuppressant macrolide SDZ RAD (also known as Everolimus E945400) which is an analog of the parent drug Rapamycin (R124000).

(19Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(19Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
jkinfo@jkchemical.com China 96815 76
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 +86-13028896684;
sales@rrkchem.com China 57423 58

  • (19Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt
  • (19E/Z)-seco-[4-O-(2-Hydroxyethyl)] RapaMycin SodiuM Salt
  • 2-Piperidinecarboxylic acid, 1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19Z,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-, sodium salt (1:1), (2S)-
  • 220127-31-1
  • C53H82NNaO14
  • Aliphatics
  • Chiral Reagents
  • Drug Analogues
  • Intermediates & Fine Chemicals
  • Metabolites & Impurities
  • Pharmaceuticals
Copyright 2019 © ChemicalBook. All rights reserved